- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Nasopharyngeal Cancers in Hong Kong
Total 1034 results
-
TakedaCompletedNon-small Cell Lung Cancer (NSCLC)Hong Kong, France, Canada
-
Daiichi Sankyo, Inc.CompletedGastric Cancer | Esophageal CancerUnited States, Canada
-
AstraZenecaCompletedNon-Small Cell Lung CancerItaly, Spain, France, Korea, Republic of, Hungary, Japan, China, Taiwan, Hong Kong, Germany, Russian Federation
-
AstraZenecaParexelCompletedMetastatic Breast CancerTaiwan, Hong Kong, Australia, Singapore, Korea, Republic of, Brazil
-
Novartis PharmaceuticalsCompleted
-
Novartis PharmaceuticalsTerminatedNon-small Cell Lung Cancer (NSCLC)Japan, Germany, Spain, Italy, France, Thailand, Belgium, Netherlands, India, Malaysia, Taiwan, Australia, Canada, Czechia, Greece, Hong Kong
-
PfizerCompletedNon-small Cell Lung Cancer With EGFR-Activating MutationsItaly, Poland, China, Hong Kong, Spain, Korea, Republic of, Japan
-
National Cancer Center, KoreaTerminatedBreast Cancer | Metastatic DiseaseKorea, Republic of
-
Shanghai Henlius BiotechRecruitingLimited-Stage Small Cell Lung CancerUnited States, China, Greece, Spain, Austria, Czechia, Germany, Hungary, Latvia, Netherlands, Poland
-
MacroGenicsCompletedCervical Cancer | Hematologic Neoplasms | Ovarian Cancer | Non Small Cell Lung Cancer | Advanced Solid Tumors | Squamous Cell Carcinoma of Head and Neck | Cholangiocarcinoma | Small-cell Lung Cancer | TNBC - Triple-Negative Breast Cancer | HER2-positive Advanced Solid TumorsHong Kong, United States, Thailand, Australia, Spain, Bulgaria, Poland, Ukraine
-
Hoffmann-La RocheCompletedHER2-Positive Early Breast CancerUnited States, Finland, Hong Kong, Panama, Portugal, Spain, Mexico, Sweden, Brazil, Serbia, Argentina, Lebanon, Cuba, Qatar, Saudi Arabia, Chile, Jordan
-
Hoffmann-La RocheCompletedGastric CancerHong Kong, Colombia, Russian Federation, Peru, Korea, Republic of, China, Mexico, Brazil, Argentina, Guatemala, Uruguay, Malaysia, Belize, Panama
-
Samsung Medical CenterNational Cancer Center, KoreaCompletedProstatic CancerKorea, Republic of
-
National Institute of Mental Health (NIMH)Completed
-
Cedars-Sinai Medical CenterNational Cancer Institute (NCI); University of California, Los Angeles; University... and other collaboratorsRecruitingBladder CancerUnited States, Japan
-
Novartis PharmaceuticalsTerminated
-
Boehringer IngelheimActive, not recruitingNeoplasms | Non-squamous, Non-Small-Cell Lung CancerUnited States, Spain, Korea, Republic of, France, Hong Kong, United Kingdom, Germany, Australia, Taiwan, Poland, Russian Federation, Ukraine
-
OPKO Health, Inc.CompletedBreast Cancer | Bone Neoplasms | Prostate Cancer | Hypocalcemia | Hyperparathyroidism, SecondaryUnited States
-
National Cancer Institute (NCI)Radiation Therapy Oncology GroupCompletedStage IA Uterine Corpus Cancer AJCC v7 | Stage IB Uterine Corpus Cancer AJCC v7 | Stage II Uterine Corpus Cancer AJCC v7 | Endometrial Clear Cell Adenocarcinoma | Endometrial Serous Adenocarcinoma | Endometrial Adenocarcinoma | Stage IIIA Uterine Corpus Cancer AJCC v7 | Stage IIIB Uterine Corpus... and other conditionsUnited States, Canada, Hong Kong
-
Rutgers, The State University of New JerseyRecruitingCardiac Toxicity | Early-stage Breast CancerUnited States
-
University of Medicine and Dentistry of New JerseyNational Cancer Institute (NCI); Aventis PharmaceuticalsTerminatedLung CancerUnited States
-
Institut de Recherche pour le DeveloppementNational Cancer Institute, France; Fondation de FranceCompletedHPV Infection and Cervical Lesions in HIV Infected Women in Thailand: A Prospective Study (PapilloV)Cervical CancerThailand
-
Myriad Genetic Laboratories, Inc.Recruiting
-
Novartis PharmaceuticalsCompletedBreast CancerCanada, Italy, Czechia, United States, Belgium, Austria, Germany, Spain, Japan, Lebanon, Australia, Bulgaria, Israel, Netherlands, Colombia, Hong Kong, Brazil
-
Xoft, Inc.TerminatedBreast CancerUnited States
-
Spectrum Pharmaceuticals, IncActive, not recruitingBreast Cancer | NeutropeniaUnited States
-
Radiation Therapy Oncology GroupNational Cancer Institute (NCI); NRG OncologyActive, not recruitingAdvanced Adult Primary Liver Cancer | Recurrent Adult Primary Liver Cancer | Adult Primary Hepatocellular CarcinomaUnited States, Canada, Australia, Hong Kong, Korea, Republic of
-
Translational Oncology Research InternationalCompletedAcinar Cell Adenocarcinoma of the Pancreas | Duct Cell Adenocarcinoma of the Pancreas | Recurrent Pancreatic Cancer | Stage III Pancreatic Cancer | Stage IIA Pancreatic Cancer | Stage IIB Pancreatic Cancer | Stage IA Pancreatic Cancer | Stage IB Pancreatic CancerUnited States
-
OncotechUnknown
-
AstraZenecaCompletedNon Small Cell Lung CancerItaly, United States, Canada, Korea, Republic of, Japan, Taiwan, Hong Kong, Spain
-
Aristotle University Of ThessalonikiNot yet recruitingMedullary Thyroid CancerChina, Switzerland, Spain, Greece, United States, Austria, Belgium, Brazil, Bulgaria, Colombia, Croatia, France, India, Iraq, Italy, Jordan, Morocco, Poland, Serbia, Slovakia, Thailand, Turkey, Ukraine, Vietnam
-
RAPT Therapeutics, Inc.Merck Sharp & Dohme LLCActive, not recruitingAdvanced CancerHong Kong, United States, Australia, Korea, Republic of, Taiwan, Thailand
-
Gilead SciencesActive, not recruitingTriple-Negative Breast CancerUnited States, United Kingdom, Australia, Hong Kong, Korea, Republic of, Taiwan
-
HUYABIO International, LLC.RecruitingCancer | Colorectal Cancer | Lung Cancer | Solid Tumor | Non Small Cell Lung Cancer | Colon Cancer | Cancer of PancreasUnited States, Puerto Rico
-
Taiho Oncology, Inc.CompletedBreast Cancer | Gastric Cancer | Cholangiocarcinoma | Urothelial Cancer | Primary CNS Tumors | Advanced and Metastatic Cancer Patients With Tumors Harboring FGF/FGFR TumorsFrance, United States, Korea, Republic of, United Kingdom, Japan, Hong Kong, Australia, Taiwan, Italy, Canada, Germany, Netherlands, Spain
-
Hoffmann-La RocheCompletedNon-Small Cell Lung CancerAustralia, Belgium, France, Italy, Hong Kong, Canada, Denmark, Taiwan, Russian Federation, United Kingdom, Spain, Hungary, Czech Republic, Poland, Germany, Netherlands
-
Translational Oncology Research InternationalGenentech, Inc.CompletedColorectal CancerUnited States
-
Hoffmann-La RocheCompletedBreast CancerFrance, United States, Spain, United Kingdom, Australia
-
PfizerCompletedNon-small Cell Lung CancerUnited States, Taiwan, Korea, Republic of, Australia, Brazil, Spain, United Kingdom, Singapore, Canada, Hong Kong, Poland, Puerto Rico
-
Novartis PharmaceuticalsRecruitingCarcinoma, Non-Small-Cell Lung | Lung Cancer | Neoplasms, Lung | Pulmonary Neoplasms | Neoplasms, Pulmonary | Pulmonary Cancer | Cancer of Lung | Cancer of the Lung | KRAS G12C Mutant Solid Tumors | Carcinoma, ColorectalUnited States, Japan, Australia, Germany, Italy, Spain, Canada, Denmark, Korea, Republic of, Taiwan, Belgium, Hong Kong, China, France, Singapore, Netherlands
-
Translational Oncology Research InternationalNational Cancer Institute (NCI); University of California, Los AngelesCompletedGastric Cancer | Esophageal CancerUnited States
-
Eagle Pharmaceuticals, Inc.CompletedCancer Which Has Either Progressed or Relapsed After Standard Therapy, or for Which no Curative or Standard Therapy is AppropriateUnited States
-
AVEO Pharmaceuticals, Inc.Biodesix, Inc.TerminatedNon-small Cell Lung CancerKorea, Republic of, United States, Australia, Taiwan, Singapore, Hong Kong, Italy
-
Hoffmann-La RocheRecruitingNon-small Cell Lung Cancer (NSCLC)Korea, Republic of, United States, China, Japan, Australia, Taiwan, Brazil, Argentina, Hong Kong
-
BioAtla, Inc.RecruitingNon-Small-Cell Lung CancerUnited States, Hong Kong, Taiwan, Spain, Greece, Germany, Italy, Poland
-
AstraZenecaRecruitingHepatocellular Carcinoma | Biliary Tract CancerChina, Spain, Korea, Republic of, Italy, United Kingdom, United States, Japan, Taiwan, Hong Kong
-
Novartis PharmaceuticalsCompletedProstate CancerUnited States
-
Hoffmann-La RocheActive, not recruitingEsophageal CancerKorea, Republic of, China, Hong Kong, Thailand, Taiwan
-
Jennerex BiotherapeuticsCompletedHCC | Hepatocellular Carcinoma | Liver CancerKorea, Republic of, United States, Hong Kong, Canada, Germany, France, Taiwan
-
PfizerActive, not recruitingHR+ HER2- Metastatic Breast Cancer, Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer, Triple Negative Breast Cancer, Male Breast CancerUnited States, Japan, Canada, Russian Federation, Bulgaria, Ukraine